Eversense 90-day

Senseonics scores coveted non-adjunctive labeling claim for Eversense CGM
By Jonah Comstock | 03:41 pm | June 07, 2019
The FDA approval closes a gap with competitors Dexcom and Abbott, as well as setting the company up for entry into the Medicare market.